Molecular Cancer Therapeutics, 19(2), 552-563. AMER ASSOC CANCER RESEARCH Okonska, A, Bühler, S, Rao, V, Ronner, M, Blijlevens, M, van der Meulen-Muileman, I H, de Menezes, R X, Wipplinger, M, Oehl, K, Smit, E F, Weder, W, Stahel, R A, Penengo, L, van Beusechem, V W & Felley-Bosco, E 2020, ' Functional genomic screen in mesothelioma reveals that loss of function of BRCA1-associated-protein-1 induces chemoresistance to ribonucleotide reductase inhibition ', Molecular Cancer Therapeutics, vol. 19, no. 2, pp. 552-563 . https://doi.org/10.1158/1535-7163.MCT-19-0356 Molecular Cancer Therapeutics, 19(2), 552-563. American Association for Cancer Research Inc.
Oncogene, 38(21), 4142-4153. Nature Publishing Group Blijlevens, M, van der Meulen-Muileman, I H, de Menezes, R X, Smit, E F & van Beusechem, V W 2019, ' High-throughput RNAi screening reveals cancer-selective lethal targets in the RNA spliceosome ', Oncogene, vol. 38, no. 21, pp. 4142-4153 . https://doi.org/10.1038/s41388-019-0711-z
Journal of extracellular vesicles, 7(1):1446660. Taylor and Francis Ltd. Berenguer, J, Lagerweij, T, Zhao, X W, Dusoswa, S, van der Stoop, P, Westerman, B, de Gooijer, M C, Zoetemelk, M, Zomer, A, Crommentuijn, M H W, Wedekind, L E, López-López, À, Giovanazzi, A, Bruch-Oms, M, Meulen-Muileman, I H V D, Reijmers, R M, van Kuppevelt, T H, García-Vallejo, J J, van Kooyk, Y, Tannous, B A, Wesseling, P, Koppers-Lalic, D, Vandertop, W P, Noske, D P, van Beusechem, V W, van Rheenen, J, Pegtel, D M, van Tellingen, O & Wurdinger, T 2018, ' Glycosylated extracellular vesicles released by glioblastoma cells are decorated by CCL18 allowing for cellular uptake via chemokine receptor CCR8 ', Journal of Extracellular Vesicles, vol. 7, no. 1, 1446660 . https://doi.org/10.1080/20013078.2018.1446660, https://doi.org/10.1080/20013078.2018.1446660 Journal of Extracellular Vesicles, 7 Journal of Extracellular Vesicles, 7, 1 Journal of Extracellular Vesicles, Vol 7, Iss 1 (2018) Journal of Extracellular Vesicles, 7(1). Taylor and Francis Ltd. Journal of Extracellular Vesicles Journal of Extracellular Vesicles, 7(1):1446660. Taylor and Francis Ltd.
Siebring-van Olst, E, Blijlevens, M, de Menezes, R X, van der Meulen-Muileman, I H, Smit, E F & van Beusechem, V W 2017, ' A genome-wide siRNA screen for regulators of tumor suppressor p53 activity in human non-small cell lung cancer cells identifies components of the RNA splicing machinery as targets for anticancer treatment ', Molecular oncology, vol. 11, no. 5, pp. 534-551 . https://doi.org/10.1002/1878-0261.12052 Molecular Oncology Molecular oncology, 11(5), 534-551. Elsevier
Clinical Cancer Research, 13(24), 7451-7458. American Association for Cancer Research Inc. Clinical Cancer Research, 13(24), 7451-8. American Association for Cancer Research Inc. Clinical cancer research, 13(24), 7451-7458. American Association for Cancer Research Inc. Lamfers, M L M, Idema, S, Bosscher, L, Heukelom, S, Moeniralm, S, van der Meulen-Muileman, I H, Overmeer, R M, van der Valk, P, van Beusechem, V W, Gerritsen, W R, Vandertop, W P & Dirven, C M F 2007, ' Differential effects of combined Ad5-delta 24RGD and radiation therapy in in vitro versus in vivo models of malignant glioma ', Clinical Cancer Research, vol. 13, no. 24, pp. 7451-8 . https://doi.org/10.1158/1078-0432.CCR-07-1265
Radiation Oncology, 10, 55 Hodzic, J, Dingjan, I, Maas, M J P, van der Meulen-Muileman, I H, Menezes, R X, Heukelom, S, Verheij, M, Gerritsen, W R, Geldof, A A, van Triest, B & van Beusechem, V W 2015, ' A cell-based high-throughput screening assay for radiation susceptibility using automated cell counting ', Radiation Oncology, vol. 10, 55 . https://doi.org/10.1186/s13014-015-0355-2 Radiation Oncology, 10:55. BioMed Central Radiation Oncology, 10, pp. 55 Radiation Oncology (London, England)
Kotov, I N, van Olst, E, Knobel, P A, van der Meulen-Muileman, I, Felley-Bosco, E, van Beusechem, V W, Smit, E F, Stahel, R A & Marti, T M 2014, ' Whole genome RNAi screens reveal a critical role of REV3 in coping with replication stress ', Molecular oncology, vol. 8, no. 8, pp. 1747-1759 . https://doi.org/10.1016/j.molonc.2014.07.008 Molecular oncology, 8(8), 1747-1759. Elsevier
Haisma, H J, Fleur Sernee, M, Hooijberg, E, Brakenhoff, R H, Meulen-Muileman, I H V D, Pinedo, H M & Boven, E 1998, ' Construction and characterization of a fusion protein of single-chain anti-CD20 antibody and human β-glucuronidase for antibody-directed enzyme prodrug therapy ', Blood, vol. 92, no. 1, pp. 184-190 . https://doi.org/10.1182/blood.v92.1.184.413k26_184_190 Blood, 92(1), 184-190. American Society of Hematology
de Bont, D B A, Leenders, R G G, Haisma, H J, van der Meulen-Muileman, I & Scheeren, H W 1997, ' Synthesis and biological activity of ß-glucuronyl-carbamate-based prodrugs of paclitaxel as potential candidates in ADEPT ', Bioorganic and Medicinal Chemistry, vol. 5, pp. 405-414 . https://doi.org/10.1016/S0968-0896(96)00249-0 Bioorganic and Medicinal Chemistry, 5, 405-414. Elsevier Limited
Abou El Hassan, MA, van der Meulen-Muileman, I, Abbas, S & Kruyt, F A E 2004, ' Conditionally replicating adenoviruses kill tumor cells via a basic apoptotic machinery-independent mechanism that resembles necrosis-like programmed cell death. ', Journal of Virology, vol. 78, no. 22, pp. 12243-51 . https://doi.org/10.1128/JVI.78.22.12243-12251.2004 Journal of Virology, 78(22), 12243-51. American Society for Microbiology